Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.
Sørensen, Benny
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. [electronic resource] - Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Jul 2003 - 469-77 p. digital
Publication Type: Journal Article
0957-5235
10.1097/00001721-200307000-00007 doi
Adult
Aged
Aged, 80 and over
Anticoagulants--adverse effects
Blood Coagulation--drug effects
Cerebral Hemorrhage--chemically induced
Computer Systems
Drug Evaluation
Factor VII--pharmacology
Factor VIIa
Female
Hematoma--chemically induced
Hemostatics--pharmacology
Humans
International Normalized Ratio
Male
Middle Aged
Recombinant Proteins--pharmacology
Thrombelastography
Thromboembolism--prevention & control
Treatment Outcome
Vitamin K--antagonists & inhibitors
Warfarin--adverse effects
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. [electronic resource] - Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Jul 2003 - 469-77 p. digital
Publication Type: Journal Article
0957-5235
10.1097/00001721-200307000-00007 doi
Adult
Aged
Aged, 80 and over
Anticoagulants--adverse effects
Blood Coagulation--drug effects
Cerebral Hemorrhage--chemically induced
Computer Systems
Drug Evaluation
Factor VII--pharmacology
Factor VIIa
Female
Hematoma--chemically induced
Hemostatics--pharmacology
Humans
International Normalized Ratio
Male
Middle Aged
Recombinant Proteins--pharmacology
Thrombelastography
Thromboembolism--prevention & control
Treatment Outcome
Vitamin K--antagonists & inhibitors
Warfarin--adverse effects